SKIN ELEMENTS LIMITED — Director's Dealing 2020

Mar 29, 2020

==> picture [587 x 90] intentionally omitted <==

27 March 2020

AMENDED APPENDIX 3Y – CHANGE OF DIRECTOR’S INTEREST NOTICE

We refer to an Appendix 3Y Change of Director’s Interest Notice lodged by Skin Elements Limited (SKN) on the ASX Market Announcements Platform (‘MAP’) on 26 March 2020 at 5.20pm for Mr Craig Piercy (‘Appendix 3Y’).

This Appendix 3Y contained a typographical error in regard to the Date of Change.

The amended Appendix 3Y is now attached and this should be read in replacement of the Appendix 3Y lodged on 26 March 2020.

This announcement is approved by the Board of Directors of Skin Elements Limited.

END

About Skin Elements

Skin Elements is an ASX-listed skin care company focused on the development of natural and organic skin care products, as an alternative to current chemical-based products. It has developed a portfolio of products which includes, the Soléo Organics 100% natural and organic sunscreen, pawpaw based PapayaActivs natural therapeutic skincare, the Elizabeth Jane Natural Cosmetics brand, and the Invisi Shield skin sanitiser range. The Company has completed a highly successful test marketing phase in major international markets for Soléo Organics and has regulatory approval with the USA FDA, TGA and other significant regulators. Skin Elements aims to become the number one recognised national and international sunscreen brand.

Further information is available via the Company website: http://skinelementslimited.com

==> picture [385 x 91] intentionally omitted <==

==> picture [512 x 34] intentionally omitted <==

==> picture [228 x 54] intentionally omitted <==

Appendix 3Y Change of Director’s Interest Notice

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity SKIN ELEMENTS LIMITED ABN 90 608 047 794

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	CRAIG PIERCY
Date of last notice	07/02/2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [403 x 251] intentionally omitted <==

----- Start of picture text -----

Direct or indirect interest Indirect
Nature of indirect interest 1. Sovereign Equities Pty Ltd
(including registered holder) 2. Equities Services Pty Ltd
Note: Provide details of the circumstances giving rise to the
relevant interest. 3. Boston Technology Management Pty Ltd
Craig Piercy is the sole director of the above
entities and the company acts as Trustee for
trusts of which Mr Piercy is a beneficiary.
Date of change 18/03/2020
No. of securities held prior to change 1. 6,855,488 Ordinary Fully Paid Shares
5,141,608 options (exp 31/12/20 @$0.10)
2. 4,642,857 Ordinary Fully Paid Shares
2,321,429 options (exp 31/12/20 @$0.10)
3. 655,785 ordinary fully paid shares
655,785 options (exp 31/12/20 @$0.10)
Class As above
----- End of picture text -----

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

==> picture [403 x 424] intentionally omitted <==

----- Start of picture text -----

Number acquired 1. 3,808,605 Ordinary Fully Paid Shares
1,269,535 unlisted options (exp 31/12/20
@$0.03)
2. 2,579,365 Ordinary Fully Paid Shares
859,789 unlisted options (exp 31/12/20
@$0.03)
3. 364,325 ordinary fully paid shares
121,442 unlisted options (exp 31/12/20
@$0.03)
Number disposed Nil
Value/Consideration $67,522
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change 1. 10,664,093 Ordinary Fully Paid Shares
5,141,608 options (exp 31/12/20 @$0.10)
1,269,535 unlisted options (exp 31/12/20
@$0.03)
2. 7,222,222 Ordinary Fully Paid Shares
2,321,429 options (exp 31/12/20 @$0.10)
859,789 unlisted options (exp 31/12/20
@$0.03)
3. 1,020,110 ordinary fully paid shares
655,785 options (exp 31/12/20 @$0.10)
121,442 unlisted options (exp 31/12/20
@$0.03)
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, Issue under pro-rata entitlement offer
participation in buy-back
----- End of picture text -----

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [408 x 298] intentionally omitted <==

----- Start of picture text -----

Detail of contract N/A
Nature of interest N/A
Name of registered holder N/A
(if issued securities)
Date of change N/A
No. and class of securities to which N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired N/A
Interest disposed N/A
Value/Consideration N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change N/A
----- End of picture text -----

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3